Heart-Monitoring Device Scores Tech Award

Posted: Updated:
The Arrhythmotech team won Innovation of the Year at TechPoint's Mira Awards. The Arrhythmotech team won Innovation of the Year at TechPoint's Mira Awards.

A technology that could alert doctors that a patient is at risk of sudden cardiac death took a top prize at the recent 18th Annual Mira Awards, presented by Indiana’s tech initiative TechPoint. Arrhythmotech’s device detects which cardiology patients are in such life-threatening situations by simply attaching sensors to the skin. Awarded Innovation of the Year in the product category at the Mira Awards, Arrhythmotech says detecting cardiac emergencies is likely just the beginning.

Based in Indianapolis at the Indiana Center for Biomedical Innovation, Arrhythmotech says its neuECG device records and processes sympathetic nerve activity and electrocardiogram signals. A conventional ECG (or EKG) focuses only on the latter measurement, but Arrhythmotech’s device adds sympathetic nerve activity to the picture.

Sympathetic nerve activity operates fundamental involuntary processes in the body, including a person’s breathing, heartbeat and digestive system. The startup will initially focus on cardiology applications; the device aims to detect patients with arrhythmia—an irregular heartbeat—and also flag patients at risk of sudden cardiac death.

Arrhythmotech Chief Executive Officer Joe Trebley says the current standard method for measuring sympathetic nerve activity is an invasive procedure that attaches electrodes directly to a nerve; Arrhythmotech’s device can capture the same information on a patient’s skin.

The technology is based on research conducted by Indiana University School of Medicine (IUSM) Medtronic Zipes Chair in Cardiology Dr. Peng-Sheng Chen. Because the technology directly measures part of the body’s stress response, the startup believes its applications reach far beyond cardiology.

Arrhythmotech is working to miniaturize the device into a wearable technology, much like a Fitbit-type product. Trebley says potential applications include predicting seizures for patients with epilepsy, monitoring performance for athletes and helping people with sleep apnea. 

“With seizures, even if you’re only right half the time, it’s good to give the patient a signal that, if you’re driving a car, you may need to pull over,” says Trebley. “Once we get this into something that’s wearable—miniaturized—I think the power is going to be demonstrated, and that’s going to be a real takeoff point for us. You can imagine patches that can tell you your stress level—something like that will be very exciting to develop over the next couple years.”

Arrhythmotech worked with Rose-Hulman Ventures to develop a beta version of the neuECG, which is being tested at IUSM and other institutions throughout the country. Trebley says the device currently consists of ECG cuffs, three leads that attach to the chest or wrist and a box slightly larger than an iPhone, “but there’s nothing insurmountable about miniaturizing it all into something that’s wearable.”

Arrhythmotech has earned two small business grants from the National Institutes of Health totaling more than $1.5 million. While the device is gaining traction in the medical space, Trebley says the Mira award validates neuECG in the tech space.

“We’re just a bunch of physicians and biomedical engineers not terribly connected within the tech community,” says Trebley. “I think a lot of what we’ll be able to unpack has to do with not just the hardware—because it’s not terribly complicated hardware—but in the software and data analytics. We’re bringing some important data to play here, and it could be really impactful. Hopefully, we’ll get some attention from [experts] in data analytics and software development and plug into those business models.”

Arrhythmotech is focusing now on “driving acceptance of [neuECG’s] technique” and conducting studies to demonstrate its predictive power.

“We’re getting interest from groups in the wearable space, or in epilepsy, or in pain, who are beginning to say, ‘This could be really interesting to plug into what we’re doing,’” says Trebley. “We’re focused on the cardiology space currently, but I think what’s really fun about this technology is, its killer application is likely to be something we haven’t even thought of yet.”

Trebley says certain applications for the neuECG will require FDA approval.
Trebley says several organizations within Indiana have played a critical role in Arrhythmotech’s development.
  • Perspectives

    • Benefits Of The 'Somewhere Between 4-40 Hour' Work Week

      Burnout. Retirement. Altered work schedules--so many conversations about this of late. Tim Ferriss of course has his 4-hour work week. If you haven't read the book, (I'd be shocked if you haven't by now), it's worth a quick read. However, as much as it's lovely to consider, I don't really think a 4-hour work week is feasible for most of us--unless we are an ex-POTUS, Brad Pitt or Tim Ferriss. On the other end of the spectrum, we have the 40-hour (or more) work week.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Benefits Of The 'Somewhere Between 4-40 Hour' Work Week

      Burnout. Retirement. Altered work schedules--so many conversations about this of late. Tim Ferriss of course has his 4-hour work week. If you haven't read the book, (I'd be shocked if you haven't by now), it's worth a quick read. However, as much as it's lovely to consider, I don't really think a 4-hour work week is feasible for most of us--unless we are an ex-POTUS, Brad Pitt or Tim Ferriss. On the other end of the spectrum, we have the 40-hour (or more) work week.

    • Fishers Sports Complex Moves Forward

      The Fishers City Council has approved the development of a more than 500,000 square-foot sports complex. Our partners at WTHR-TV report construction on the nearly $75 million project could begin as early as this fall. The Fishers Sports & Entertainment Complex is set to be located near the intersection of 136th Street and Olio Road. 

    • 'Unprecedented' Growth Drives Jayco Expansion

      Jayco Inc. has announced what it calls a new "mega-facility" planned at its Middlebury campus. The recreational vehicle manufacturer says the 237,000 square-foot operation will create approximately 300 jobs. Officials expect to break ground late next month. The new facility will house two additional Jay Flight travel trailer lines and help boost efficiency for other brands. Jayco was acquired in late 2016 by Elkhart-based Thor Industries (NYSE: THO) for $576 million.

    • Sun King Unveils Carmel Distillery Details

      Sun King Brewing Co.'s co-founder and head brewer says, if weather cooperates, its $4 million distillery in Carmel could open in April. Dave Colt says the facility will use a 250-gallon still to craft spirits including artisan moonshine, gin and rum. The distillery will also feature four food vendors, which the brewery says will be announced later. Colt says Carmel has invested a lot of time and money to "enhance our front door," which overlooks the...

    • Collective Alternative Hires Misencik as Director

      Indianapolis-based Collective Alternative, a full-service marketing, advertising and public relations firm, has hired Nicole Misencik as director of client services. She previously worked for nine years as a meteorologist at WTHR-TV in Indianapolis.